Rebecca Lynn Wright, DO | |
304 S 29th St, Chickasha, OK 73018-2501 | |
(405) 896-8058 | |
Not Available |
Full Name | Rebecca Lynn Wright |
---|---|
Gender | Female |
Speciality | General Practice |
Experience | 13 Years |
Location | 304 S 29th St, Chickasha, Oklahoma |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1801183249 | NPI | - | NPPES |
200441600B | Medicaid | OK |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 5288 (Oklahoma) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Shanadoa Home Health Inc | Bartlesville, OK | Home health agency |
Amedisys Home Health | Bartlesville, OK | Home health agency |
Seasons Hospice, Inc | Tulsa, OK | Hospice |
Wagoner Community Hospital | Wagoner, OK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Sand Springs Medical Associates | 9436210580 | 7 |
News Archive
In an effort to improve treatment and one day find a cure for pancreatic cancer, the TGen Foundation today joined with key donors and community leaders to announce the creation of globalCure.
Obstructive Sleep Apnea (OSA) remains under-recognized in hospitalized patients, despite being associated with cardiovascular complications and sudden death. A multi-disciplinary group of researchers and physicians at Thomas Jefferson University and Hospitals have created a clinical pathway, or screening process, to identify the disorder in higher-risk, hospitalized patients and recently published the results in the Journal of Clinical Sleep Medicine.
As Covid-19 continues to put pressure on healthcare providers around the world, engineers at the University of Bath have published a mathematical model that could help clinicians to safely allow two people to share a single ventilator.
Bristol-Myers Squibb Company and Ambrx, Inc. today announced a collaboration under which Bristol-Myers Squibb will receive exclusive worldwide rights to research, develop and commercialize biologics based on Ambrx's research surrounding the Fibroblast Growth Factor 21 protein, for potential use in treating type 2 diabetes, and the Relaxin hormone, for potential use in treating heart failure.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the debut of its new LED Fiber Optic Illuminator Module. The new LED Module is designed for ease of integration by medical OEMs in endoscopy, surgical microscopy and headlamp applications.
› Verified 6 days ago
Entity Name | Sand Springs Medical Associates |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1497922496 PECOS PAC ID: 9436210580 Enrollment ID: O20081208000160 |
News Archive
In an effort to improve treatment and one day find a cure for pancreatic cancer, the TGen Foundation today joined with key donors and community leaders to announce the creation of globalCure.
Obstructive Sleep Apnea (OSA) remains under-recognized in hospitalized patients, despite being associated with cardiovascular complications and sudden death. A multi-disciplinary group of researchers and physicians at Thomas Jefferson University and Hospitals have created a clinical pathway, or screening process, to identify the disorder in higher-risk, hospitalized patients and recently published the results in the Journal of Clinical Sleep Medicine.
As Covid-19 continues to put pressure on healthcare providers around the world, engineers at the University of Bath have published a mathematical model that could help clinicians to safely allow two people to share a single ventilator.
Bristol-Myers Squibb Company and Ambrx, Inc. today announced a collaboration under which Bristol-Myers Squibb will receive exclusive worldwide rights to research, develop and commercialize biologics based on Ambrx's research surrounding the Fibroblast Growth Factor 21 protein, for potential use in treating type 2 diabetes, and the Relaxin hormone, for potential use in treating heart failure.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the debut of its new LED Fiber Optic Illuminator Module. The new LED Module is designed for ease of integration by medical OEMs in endoscopy, surgical microscopy and headlamp applications.
› Verified 6 days ago
Entity Name | Squareone Compassion Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1508493784 PECOS PAC ID: 6507296845 Enrollment ID: O20200428001983 |
News Archive
In an effort to improve treatment and one day find a cure for pancreatic cancer, the TGen Foundation today joined with key donors and community leaders to announce the creation of globalCure.
Obstructive Sleep Apnea (OSA) remains under-recognized in hospitalized patients, despite being associated with cardiovascular complications and sudden death. A multi-disciplinary group of researchers and physicians at Thomas Jefferson University and Hospitals have created a clinical pathway, or screening process, to identify the disorder in higher-risk, hospitalized patients and recently published the results in the Journal of Clinical Sleep Medicine.
As Covid-19 continues to put pressure on healthcare providers around the world, engineers at the University of Bath have published a mathematical model that could help clinicians to safely allow two people to share a single ventilator.
Bristol-Myers Squibb Company and Ambrx, Inc. today announced a collaboration under which Bristol-Myers Squibb will receive exclusive worldwide rights to research, develop and commercialize biologics based on Ambrx's research surrounding the Fibroblast Growth Factor 21 protein, for potential use in treating type 2 diabetes, and the Relaxin hormone, for potential use in treating heart failure.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the debut of its new LED Fiber Optic Illuminator Module. The new LED Module is designed for ease of integration by medical OEMs in endoscopy, surgical microscopy and headlamp applications.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Rebecca Lynn Wright, DO Po Box 929, Chickasha, OK 73023-0929 Ph: (405) 896-8058 | Rebecca Lynn Wright, DO 304 S 29th St, Chickasha, OK 73018-2501 Ph: (405) 896-8058 |
News Archive
In an effort to improve treatment and one day find a cure for pancreatic cancer, the TGen Foundation today joined with key donors and community leaders to announce the creation of globalCure.
Obstructive Sleep Apnea (OSA) remains under-recognized in hospitalized patients, despite being associated with cardiovascular complications and sudden death. A multi-disciplinary group of researchers and physicians at Thomas Jefferson University and Hospitals have created a clinical pathway, or screening process, to identify the disorder in higher-risk, hospitalized patients and recently published the results in the Journal of Clinical Sleep Medicine.
As Covid-19 continues to put pressure on healthcare providers around the world, engineers at the University of Bath have published a mathematical model that could help clinicians to safely allow two people to share a single ventilator.
Bristol-Myers Squibb Company and Ambrx, Inc. today announced a collaboration under which Bristol-Myers Squibb will receive exclusive worldwide rights to research, develop and commercialize biologics based on Ambrx's research surrounding the Fibroblast Growth Factor 21 protein, for potential use in treating type 2 diabetes, and the Relaxin hormone, for potential use in treating heart failure.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the debut of its new LED Fiber Optic Illuminator Module. The new LED Module is designed for ease of integration by medical OEMs in endoscopy, surgical microscopy and headlamp applications.
› Verified 6 days ago